The U.S. Drug Enforcement Administration (DEA) recently announced new rules that will impact telemedicine practices, especially concerning ...

The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...

The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...

The DEA’s proposed 50/50 telehealth rule undermines the accessibility and effectiveness of psychiatric care by imposing unnecessary in-person visit requirements. Here's how.

But the DEA did not implement that part of the law, preventing providers from prescribing controlled substances through telehealth until such restrictions were waived during the COVID-19 pandemic.

In this proposed rulemaking’s approach, DEA distinguishes telemedicine providers by architecting three distinct categories subject to different levels of scrutiny. The first special registration ...

Opens in a new tab or window Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule ...

via telemedicine. The move finally fulfills a mandate that DEA had largely ignored since Congress first issued it in 2008. But the new special registration system is merely a proposal ...

When the DEA issued its final rule in November on the fate of telehealth flexibilities created during the pandemic, it confirmed that DEA-registered practitioners can write prescriptions without ...

Congress first directed the DEA to create the special registration program in 2008. That law prevented providers from prescribing controlled substances through telehealth unless they received such ...